The vaccine Development Pathway

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The decision to develop a vaccine is based on analysis of need and, in most cases, potential returns on the significant investment of time and resources required to move a candidate product from initial development through to licensure. The vaccine development pathway encompasses a series of highly regulated milestones designed to assess the safety and efficacy of a candidate vaccine via nonclinical testing, using animal models and in vitro assays, and in phased clinical trials in humans. Regulatory oversight also aims to ensure the consistency of its manufacture during the investigational phases and following its approval and licensure.

Original languageEnglish (US)
Title of host publicationVaccinology: An Essential Guide
PublisherWiley Blackwell
Pages33-42
Number of pages10
ISBN (Electronic)9781118638033
ISBN (Print)9780470656167
DOIs
StatePublished - Dec 9 2014

Keywords

  • Biologics license application
  • Clinical trials
  • Investigational new drug
  • National regulatory authority
  • Nonclinical testing

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The vaccine Development Pathway'. Together they form a unique fingerprint.

  • Cite this

    Beasley, D. W. C. (2014). The vaccine Development Pathway. In Vaccinology: An Essential Guide (pp. 33-42). Wiley Blackwell. https://doi.org/10.1002/9781118638033.ch2